Rx · PZN 16517047, 18116631
MVASI 25 mg/ml 400mg concentrate for preparation of a solution for infusion vial
German trade nameMVASI 25 mg-ml 400mg Konzentrat zur Herstellung einer Infusionslösung Durchstechflasche
Only sporadically available
1.0out of 10
Storage temperature and transport temperature
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for MVASI 25 mg/ml 400mg concentrate for preparation of a solution for infusion vial.
Review purchasing termsMVASI 25 mg/ml 400mg concentrate for preparation of a solution for infusion vial contains the active ingredient Bevacizumab and comes as Concentrate for solution for infusion. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 1.0 out of 10. The best-available pack was only sporadically available. 1 of the 2 packs are currently marketed according to our records.
Pack sizes · 2 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 16517047 | 0.4 | 1.0 | ~ €523 |
| 18116631 | 0.0 | 0.0 | ~ €511 |
MVASI 25 mg/ml 400mg concentrate for preparation of a solution for infusion vial was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.
Request a source of supply